Key result
Zero-fluoroscopy catheter ablation successfully terminated drug-refractory focal atrial tachycardia in a pregnant woman, resulting in no recurrences and near-normal improvement of left ventricular systolic function.
Why the study?
Does zero-fluoroscopy catheter ablation safely and effectively treat focal atrial tachycardia in a pregnant woman with tachycardia-induced cardiomyopathy?
Case Report (n=1)
No
Does zero-fluoroscopy catheter ablation safely and effectively treat focal atrial tachycardia in a pregnant woman with tachycardia-induced cardiomyopathy?
Zero-fluoroscopy catheter ablation using 3D-electroanatomic mapping and intracardiac echocardiography is a safe and effective treatment for drug-refractory atrial tachycardia during pregnancy.
May offer a treatment option for drug-refractory tachycardias in pregnancy; leaves open the need for prospective confirmation before practice change.
Introduction: Occurrence of tachycardias increase during pregnancy in line with the increased propensity to ectopic activity.Case presentation: We present a case of a 30-year-old woman in the 18th week of pregnancy with atrial tachycardia and tachycardia-induced cardiomyopathy that was successfully treated with zero fluoroscopy catheter ablation.Discussion: The described method is safe and efficient and could be used in the future when drug refractory tachycardias occur during pregnancy.
No takes yet. Share an insight, caveat, or question.
Jug et al. (2018) conducted a case report in Atrial tachycardia and tachycardia-induced cardiomyopathy (n=1). Zero-fluoroscopy catheter ablation was evaluated on Termination of atrial tachycardia. Zero-fluoroscopy catheter ablation successfully terminated drug-refractory focal atrial tachycardia in a pregnant woman, resulting in no recurrences and near-normal improvement of left ventricular systolic function.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: